
Gelteq Ltd (GELS)
NASDAQ
The current GELS market cap is 13.48M. The company's latest EPS is AUD -0.3757 and P/E is -3.81.
Quarter End | ||
---|---|---|
AUD (AUD) | AUD (AUD) | |
Total Revenue | ||
Operating Income | ||
Net Income |
Year End June 29 2024 | 2023 | 2024 |
---|---|---|
AUD (AUD) | AUD (AUD) | |
Total Revenue | 566k | 143k |
Operating Income | -3.16M | -2.78M |
Net Income | -3.51M | -3.55M |
Quarter End | ||
---|---|---|
AUD (AUD) | AUD (AUD) | |
Total Assets | ||
Total Liabilities | ||
Total Equity |
Year End June 29 2024 | 2023 | 2024 |
---|---|---|
AUD (AUD) | AUD (AUD) | |
Total Assets | 22.5M | 20.76M |
Total Liabilities | 3.84M | 5.65M |
Total Equity | 18.66M | 15.11M |
Market Cap | 13.48M |
Price to Earnings Ratio | -3.81 |
Price to Sales Ratio | 94.08 |
Price to Cash Ratio | 550 |
Price to Book Ratio | 0.89 |
Dividend Yield | - |
Shares Outstanding | 9.44M |
Average Volume (1 week) | 26.64k |
Average Volume (1 Month) | 20.59k |
52 Week Change | -64.30% |
52 Week High | 5.50 |
52 Week Low | 1.18 |
Spread (Intraday) | 0.07 (4.93%) |
Company Name | Gelteq Ltd |
Address |
level 4 melbourne, victoria 3025 |
Website | https://www.gelteq.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.